“In order to produce commercially viable EPA omega-3 oils from microalgae, it is necessary to have an organism that simultaneously produces sufficient quantities of both oil and EPA,” said Dr. Charles Roe, chief technology officer of AlgiSys.
AlgiSys has been working on the development of an algal species, creating culture conditions that meet these requirements and allows for the economical production of an all-natural, vegan source of high-quality omega-3 oils. AlgiSys expects to begin producing product within the next 12 months.
“This patent is extremely valuable, as the Omega-3 market is a multi-billion dollar business that continues to grow globally. EPA omega-3 is one of the critical components found in today’s fish oil products. There was no sustainable, natural source for oils rich in this omega-3 fatty acid alone—until now,” said AlgiSys CEO, Michael LoPresti.
Algisys’ initial research phase has been successfully completed and the company is currently forming fruitful relationships with industry partners to take this high-value product to market.